Professor Kawauchi’s project, ‘Identification of Novel Therapeutic Targets through the Development of Pediatric Brain Tumor Models Using Human ES Cell-Derived Brain Organoids,’ has been selected for the 2024 Kawano Pediatric Medical Scholarship Foundation Research Grant. This research aims to create pediatric brain tumor models from human ES cells and develop new therapies.

Dr. Kawauchi’s project, ‘Exploration of Therapeutic Target Molecules through Epigenomic Analysis of Medulloblastoma,’ has been awarded the 2023 Astellas Foundation for Research on Metabolic Disorders Research Grant. Over the next two years, we aim to elucidate the mechanisms that regulate the unique epigenome of medulloblastoma.

P.S.: With this support, our paper has been accepted by Developmental Cell. You can find the paper here.

川内教授が次世代がん医療加速化研究事業（P-PROMOTE）領域Aと領域Bにそれぞれ研究代表者および分担研究者（代表：TMDU上阪直史教授）として採択されました。
領域Aは脳腫瘍のエピゲノム研究、領域Bはがんと神経のコミュニケーションに関する研究です。
皆様よろしくお願い致します。

川内が東京医科歯科大学上阪直史教授との共同研究内容「Conditional expression and activation of DREADDs reveals novel impact of neuron-tumor communications on brain tumor progression」を Cancer Neuroscience Conference Heidelberg で口頭発表しました。
脳腫瘍と神経細胞のコミュニケーションの話です。興味がある方は是非ご連絡ください。

The Kawauchi group participated in the fundraising activities of the German Brain Tumor Research Foundation’s ‘Ein KIWI gegen Krebs‘ by taking a team photo from Japan. This initiative aims to unite teams globally to combat pediatric cancer.